Role of FAT/CD36 in novel PKC isoform activation in heart of spontaneously hypertensive rats

. 2011 Nov ; 357 (1-2) : 163-9. [epub] 20110531

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid21625957

Disruption to the sensitive balance of long-chain fatty acids and glucose in the heart could cause cardiovascular diseases. Searching for a possible role of novel protein kinase C (nPKC) in heart with disrupted energy balance, we compared the insulin-resistant spontaneously hypertensive rats (SHR), which carry a nonfunctional variant of the fatty acid transporter FAT/CD36, with the less insulin-resistant congenic strain SHR-4 that is genetically identical except for a segment on chromosome 4 including a wild-type gene for a functional FAT/CD36. We analyzed expression of the nPKC-δ and -ε isoforms plus triacylglycerols (TAG) content in the myocardium of both FAT/CD36 strains and after a high sucrose diet (HSD). Two weeks before killing, males of both strains were randomly divided into two groups and fed either a standard laboratory chow or an HSD. PKC was determined by Western blotting in particulate and cytosolic fractions from left ventricles. The SHR-4 rats exhibited lower serum levels of insulin and free fatty acids than did SHR rats and higher amounts of PKC-ε in the heart particulate fraction. HSD caused accumulation of heart TAG in SHR but not in SHR-4. HSD increased PKC-δ and decreased PKC-ε expression in particulate fraction from left ventricles of SHR-4 while having no effects in SHR. These results demonstrate that reduced insulin resistance in SHR-4 rats with wild-type FAT/CD36 is associated with the insulin signaling pathway involving nPKCs.

Zobrazit více v PubMed

Proc Nutr Soc. 2004 May;63(2):251-8 PubMed

Am J Physiol Endocrinol Metab. 2003 May;284(5):E923-30 PubMed

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H224-30 PubMed

Nat Genet. 1999 Jan;21(1):76-83 PubMed

Nat Genet. 2001 Feb;27(2):156-8 PubMed

J Endocrinol. 2009 May;201(2):199-209 PubMed

Diabetologia. 2007 Sep;50(9):1938-1948 PubMed

Cell Metab. 2007 Oct;6(4):320-8 PubMed

Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2571-81 PubMed

Diabetes. 2002 Oct;51(10):3113-9 PubMed

J Biol Chem. 2000 Sep 29;275(39):29927-30 PubMed

FASEB J. 1995 Apr;9(7):484-96 PubMed

Biochim Biophys Acta. 2005 Oct 1;1736(3):163-80 PubMed

Life Sci. 2002 Aug 2;71(11):1303-12 PubMed

Am J Physiol. 1999 Dec;277(6):E1070-6 PubMed

Anal Biochem. 1977 Dec;83(2):346-56 PubMed

Mol Cell Biochem. 2007 May;299(1-2):5-18 PubMed

J Mol Cell Cardiol. 1994 Oct;26(10):1371-5 PubMed

Curr Hypertens Rep. 2007 Dec;9(6):450-4 PubMed

Biochem J. 2011 Jul 1;437(1):125-34 PubMed

Mol Cell Biochem. 2003 Jan;242(1-2):145-52 PubMed

J Mol Endocrinol. 2010 Mar;44(3):155-69 PubMed

Curr Opin Clin Nutr Metab Care. 2002 Mar;5(2):139-45 PubMed

Circulation. 2002 Jul 9;106(2):239-45 PubMed

J Biol Chem. 2008 Apr 25;283(17):11226-33 PubMed

J Biol Chem. 2001 Jun 29;276(26):23661-6 PubMed

Metabolism. 2008 Jul;57(7):911-9 PubMed

J Cell Sci. 1997 Jul;110 ( Pt 14):1625-34 PubMed

Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1425-36 PubMed

J Clin Invest. 1999 Jun;103(12):1651-7 PubMed

Mol Cell Biochem. 2010 Dec;345(1-2):271-82 PubMed

Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1343-50 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...